LILRA4 and cancer: The crosslinking of ILT7 and BST2 strongly inhibits the production of IFN-α and proinflammatory cytokines (e.g. TNF-α) by pDCs [143, 149, 150]; however, the role of this interaction in cancer is still unclear.